Palivizumab (MEDI 493) is a humanized RSV-specific monoclonal antibody that selectively inhibits epitopes at the F protein A antigenic site of RSV subtypes A and B for the prevention of respiratory syncytial virus infection (RSV).

Nirsevimab (MEDI8897) is a recombinant human respiratory syncytial virus (RSV) monoclonal antibody with a modified Fc region, efficiently targeting RSV-B with a Kd value of 1.5 nM, and can be used to prevent RSV infection.

Clesrovimab (MK1654) is an anti-respiratory syncytial virus protein F human monoclonal antibody for the prevention and treatment of respiratory syncytial virus infections.

TNM001 is an anti-RSV fully humanized monoclonal antibody for the study of lower respiratory tract disease due to RSV infection.

Tixagevimab (AZD8895) is a humanized monoclonal antibody targeting the spike protein of SARS-CoV-2, with antiviral activity. It works by binding to the RBD and S protein domain, blocking the interaction with receptors.

Actoxumab is a humanized monoclonal antibody targeting Clostridium difficile toxin A (TcdA), preventing the binding of TcdA to target cells and neutralizing toxin activity by inhibiting the first step of TcdA.

Leronlimab (PRO 140) is a humanized IgG4 anti-CCR5 monoclonal antibody with both anti-HIV and anti-tumor activity, inhibiting CCR-mediated HIV-1 virus and cancer cell metastasis in mouse tumor models. Leronlimab can be used to study HIV, non-alcoholic steatohepatitis (NASH), and breast cancer.

AM14 is a human monoclonal antibody with the unique ability to bind pre-fusion F epitopes (PreF) and recognize the quality of trimer-specific epitopes.

Rafivirumab (CR57) is a monoclonal antibody targeting the rabies virus G protein, used in the study of rabies virus infection.

Romlusevimab (BRII-198) is a recombinant antibody targeting the spike protein of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), with antiviral activity, used for research on COVID-19 infection.

Gontivimab (ALX-0171) is a trivalent nanobody targeting the hRSV fusion (F) protein with anti-RSV antiviral properties for the study of respiratory syncytial virus infections.

S2H97 is a neutralizing antibody that broadly protects against viruses such as C pneumoniae and SARS under clade B of coronavirus B. RSM01 is a fully human monoclonal antibody against RSV.

Sotrovimab (VIR 7831) is a monoclonal antibody against the SARS-CoV-2 virus that causes COVID-19. It has antiviral activity, induces serum neutralization of BQ.1 and antibody-dependent cytotoxicity, and may be used to study viral infections.

Foravirumab (CR4098) is a monoclonal antibody targeting rabies virus glycoprotein (RABV-G) for the study of infectious diseases such as rabies.

Odesivimab (REGN-3471) is a human monoclonal antibody targeting the Zaire strain of Ebola virus, with potential antiviral activity, used for research on Ebola virus infection.

Cilgavimab (AZD-1061) is a humanized monoclonal antibody targeting the spike protein of SARS-CoV-2, used in studies of COVID-19 infection.

RSM01 is a fully human IgG1 monoclonal antibody that targets a site in the pre-F region of RSV with a YTE half-life prolongation mutation.

Motavizumab (MEDI-524) is a monoclonal antibody neutralizing respiratory syncytial virus (RSV), altering local and systemic cytokine responses in mouse models, used in the study of RSV infection.

The Anti-West Nile/dengue virus E protein Antibody (E60) is a mouse-derived IgG2akappa antibody targeting the West Nile/dengue virus E protein. Its isotype control is MouseIgG2akappa, Isotype Control.

ADI-15878 is a human IgG monoclonal antibody (mAb) specifically targeting the envelope glycoprotein GP2. It can be utilized for research on Ebola virus infection. The recommended isotype control is Human IgG1 kappa, Isotype Control.

Anti-HMPV-F Antibody (MPV467) is an antibody. Its expression system is CHO cells, the clone number is MPV467, and the isotype control is IgG1, Lambda.

Anti-HMPV-F Antibody (SAN32-2) is an antibody. Its expression system is CHO cells, the clone number is SAN32-2, and the isotype control is IgG1, Kappa.

Anti-SARS-CoV-2 Spike Antibody (6A521) is a Mouse IgG2b monoclonal antibody targeting SARS-CoV-2 SARS-CoV-2 Spike.

Anti-SARS-CoV-2 Spike Antibody (1H528) is a Rabbit IgG monoclonal antibody targeting SARS-CoV-2 SARS-CoV-2 Spike.